Vringo (VRNG) has been the fortunate recipient of some very interesting news over the past few days. First the judge ruled that Google's workaround is not really a workaround and that they still owe Vringo royalties. The second and possibly bigger ruling came when the judge even enhanced the royalty rate to 6.5% of the royalty base of Google's US revenues. This could be an interesting stock to watch and expect a Seeking Alpha article out later on Vringo's recent developments.
Stock Ideas for Average investors is about people finding out ideas for stocks that they would potentially invest in. This blog is focused more on the biotechnology side of the industry, however other stock suggestions are more than welcome.
Popular Posts
-
BPAX is one of my top recommendations. Biosante is a pharmaceutical company whose principal product is a gel, which is being tested to impro...
-
Just today Dendreon Corporation (DNDN) announced "corporate restructuring" and that it would cut approximately 500 jobs. This come...
-
Generex Pharmaceuticals (GNBT)- Has for years been promising, and promising, and promising... yet nothing has been delivered. Generex has m...
Friday, January 31, 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment